Aarti Pharmalabs Limited (AARTIPHARM.BO)
INR 577.0
(2.11%)
INR 577.0
(2.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.12 Billion INR | 10.99% |
| 2022 | 2.81 Billion INR | 366214.11% |
| 2021 | -769.76 Thousand INR | -1574.85% |
| 2020 | -45.96 Thousand INR | 75.39% |
| 2019 | -186.75 Thousand INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 727.9 Million INR | -4.59% |
| 2024 Q1 | 762.93 Million INR | -22.47% |
| 2023 Q3 | 783 Million INR | 10.55% |
| 2023 FY | 3.12 Billion INR | 10.99% |
| 2023 Q4 | 984 Million INR | 25.67% |
| 2023 Q2 | 708.3 Million INR | 3.93% |
| 2023 Q1 | 681.5 Million INR | 3.81% |
| 2022 Q3 | 693.99 Million INR | -5.19% |
| 2022 FY | 2.81 Billion INR | 366214.11% |
| 2022 Q2 | 732 Million INR | 11.5% |
| 2022 Q1 | 656.49 Million INR | -20.35% |
| 2022 Q4 | 656.49 Million INR | -5.4% |
| 2021 Q2 | -77.51 Thousand INR | 0.0% |
| 2021 Q1 | -77.51 Thousand INR | 0.0% |
| 2021 Q4 | 824.19 Million INR | -0.0% |
| 2021 Q3 | 824.21 Million INR | 1063355.65% |
| 2021 FY | -769.76 Thousand INR | -1574.85% |
| 2020 FY | -45.96 Thousand INR | 75.39% |
| 2019 FY | -186.75 Thousand INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ajanta Pharma Limited | 19.67 Billion INR | 84.103% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -583.675% |
| Sigachi Industries Limited | 1.47 Billion INR | -112.235% |
| Bal Pharma Limited | 233.9 Million INR | -1237.322% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | 29.237% |
| Medico Remedies Limited | 100.3 Million INR | -3018.76% |
| Lasa Supergenerics Limited | -458 Million INR | 782.987% |
| Venus Remedies Limited | 534.65 Million INR | -485.076% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 176.017% |
| Alpa Laboratories Limited | 184.49 Million INR | -1595.483% |
| Nectar Lifesciences Limited | 923.8 Million INR | -238.612% |
| Shilpa Medicare Limited | 1.36 Billion INR | -128.953% |
| Aarti Drugs Limited | 7.14 Billion INR | 56.242% |
| Lupin Limited | 28.04 Billion INR | 88.846% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 92.588% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 92.743% |
| Windlas Biotech Limited | 1.29 Billion INR | -140.83% |
| Suven Life Sciences Limited | -1.22 Billion INR | 355.185% |
| Eris Lifesciences Limited | 5.18 Billion INR | 39.632% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 78.099% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 181.189% |
| Ipca Laboratories Limited | 7.98 Billion INR | 60.803% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -154.112% |
| Achyut Healthcare Limited | 4.43 Million INR | -70384.813% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 97.001% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| RPG Life Sciences Limited | 2.29 Billion INR | -36.462% |
| Mankind Pharma Limited | 21.51 Billion INR | 85.463% |
| Laurus Labs Limited | 3.94 Billion INR | 20.779% |
| Piramal Pharma Limited | 4.55 Billion INR | 31.354% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -1155.006% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 87.653% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 45.675% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 51.893% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -399.3% |
| Wanbury Limited | 569.71 Million INR | -449.066% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 32.11% |
| Wockhardt Limited | -670 Million INR | 566.883% |
| Themis Medicare Limited | 392.58 Million INR | -696.792% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -515.613% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 39.716% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 65.163% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 95.381% |
| Divi's Laboratories Limited | 33.08 Billion INR | 90.544% |
| NATCO Pharma Limited | 25.96 Billion INR | 87.951% |
| Gufic Biosciences Limited | 1.32 Billion INR | -135.213% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -95.899% |
| Ind-Swift Limited | 1.22 Billion INR | -155.156% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -12.28% |
| FDC Limited | 2.98 Billion INR | -4.752% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 2158.553% |
| Granules India Limited | 6.81 Billion INR | 54.111% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Alkem Laboratories Limited | 19.46 Billion INR | 83.927% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -82.132% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -34393.544% |
| Brooks Laboratories Limited | 14.44 Million INR | -21562.853% |
| Megasoft Limited | -121.1 Million INR | 2683.0% |
| ZIM Laboratories Limited | 253.82 Million INR | -1132.371% |
| Strides Pharma Science Limited | 5.22 Billion INR | 40.141% |
| Neuland Laboratories Limited | 5.31 Billion INR | 41.18% |
| Morepen Laboratories Limited | 4.17 Billion INR | 25.054% |
| Hikal Limited | 32.11 Million INR | -9641.875% |
| Indoco Remedies Limited | 1.29 Billion INR | -142.011% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -1403.54% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -11292.367% |
| Hester Biosciences Limited | 364.81 Million INR | -757.464% |